Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.
| Author | |
|---|---|
| Abstract | :
To assess stroke/systemic embolism, major bleeding and other outcomes, and treatment effect of apixaban versus warfarin, in patients with atrial fibrillation (AF) and different types of valvular heart disease (VHD), using data from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. |
| Year of Publication | :
2018
|
| Journal | :
Heart (British Cardiac Society)
|
| Date Published | :
2018
|
| ISSN Number | :
1355-6037
|
| URL | :
http://heart.bmj.com/cgi/pmidlookup?view=long&pmid=29352007
|
| DOI | :
10.1136/heartjnl-2017-312272
|
| Short Title | :
Heart
|
| Download citation |